Aytu Biopharma (AYTU) Long-Term Deferred Tax (2015 - 2023)

Aytu Biopharma (AYTU) has 6 years of Long-Term Deferred Tax data on file, last reported at $100000.0 in Q2 2023.

• On a quarterly basis, Long-Term Deferred Tax changed N/A year-over-year to $100000.0 in Q2 2023; TTM through Jun 2023 was $100000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $100000.0, changed N/A from the prior year.
• Long-Term Deferred Tax for Q2 2023 stood at $100000.0, down from $39.6 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for AYTU reached as high as $39.6 million in Q2 2020 and fell as low as $100000.0 in Q2 2023.
• Historically, Long-Term Deferred Tax has averaged $19.2 million across 3 years, with a median of $18.1 million in 2019.
• Across the five-year window, Long-Term Deferred Tax gained 25.09% in 2019 and soared 118.7% in 2020, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $18.1 million in 2019, then jumped by 118.7% to $39.6 million in 2020, then slumped by 99.75% to $100000.0 in 2023.
• Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $100000.0 in Q2 2023, $39.6 million in Q2 2020, and $18.1 million in Q2 2019.